Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Embryonal Brain Tumor Not Otherwise Specified: early-phase trial registry

1 of 1 indexed Embryonal Brain Tumor Not Otherwise Specified trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Embryonal Brain Tumor Not Otherwise Specified: 1 US clinical trial tracked, 1 recruiting.

Embryonal Brain Tumor Not Otherwise Specified is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's National Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition embryonal-brain-tumor-not-otherwise-specified

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Embryonal Brain Tumor No (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Embryonal Brain Tumor Not Otherwise Specified

Embryonal Brain Tumor Not Otherwise Specified lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Embryonal Brain Tumor Not Otherwise Specified on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Embryonal Brain Tumor Not Otherwise Specified is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Embryonal Brain Tumor Not Otherwise Specified records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Group B Salvage Backbone Therapy Radiation
1 trials
Group A Standard-of-Care Backbone Therapy Drug
1 trials
Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized tumor-specific antigens (TSA) Biological
1 trials

US sites by state

Facility locations filed on Embryonal Brain Tumor Not Otherwise Specified trials. A trial with sites in several states counts in each.

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Embryonal Brain Tumor Not Otherwise Specified page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Embryonal Brain Tumor Not Otherwise Specified condition card totals 1 registered trials; most-linked intervention Group B Salvage Backbone Therapy; top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.